Global Urinary Incontinence Treatment Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Urethral Slings - Female Slings and Male Slings, Electrical Stimulation Devices - Implantable and Non-Implantable, and Artificial Urinary Sphincters.By Incontinence;
Stress Urinary Incontinence, Urge Urinary Incontinence, Mixed Incontinence, and Overflow Incontinence.By Category;
Internal Incontinence Devices and External Incontinence Devices.By End User;
Hospitals, Ambulatory Surgery Centers, Clinics, and Home Care.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Urinary Incontinence Treatment Devices Market (USD Million), 2021 - 2031
In the year 2024, the Global Urinary Incontinence Treatment Devices Market was valued at USD 6,728.03 million. The size of this market is expected to increase to USD 11,249.64 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.6%.
The global urinary incontinence treatment devices market has been witnessing steady growth over the past decade, fueled by a rising prevalence of urinary incontinence, particularly among the aging population worldwide. Urinary incontinence, a common condition characterized by the loss of bladder control, has emerged as a significant public health concern, prompting increased demand for effective treatment options. As a result, manufacturers have been actively innovating and introducing advanced urinary incontinence treatment devices to address the diverse needs of patients.
One of the key drivers propelling market growth is the growing awareness regarding urinary incontinence and its impact on the quality of life. With greater understanding and acceptance of this condition, more individuals are seeking medical intervention and management solutions, thereby driving the demand for urinary incontinence treatment devices. Additionally, advancements in medical technology have led to the development of minimally invasive and highly efficacious devices, offering patients safer and more convenient treatment options.
The expanding geriatric population, particularly in developed regions, is anticipated to bolster market expansion. Aging is a major risk factor for urinary incontinence, and as the elderly population grows, the prevalence of this condition is expected to rise significantly, necessitating the adoption of urinary incontinence treatment devices. Moreover, favorable government initiatives aimed at promoting awareness about urinary incontinence and improving access to healthcare services are likely to further stimulate market growth in the coming years.
Despite the promising prospects, the market faces challenges such as high costs associated with advanced treatment devices and limited reimbursement policies in certain regions. Nevertheless, ongoing research and development activities aimed at introducing cost-effective solutions and expanding market reach are anticipated to mitigate these challenges, fostering continued growth in the global urinary incontinence treatment devices market.
Global Urinary Incontinence Treatment Devices Market Recent Developments
-
December 2022, Axonics, Inc. announced that Health Canada has approved the company's fourth-generation rechargeable sacral neuromodulation system. It provides safe and durable symptom relief to women with stress urinary incontinence (SUI).
-
May 2022, BlueWind Medical, Ltd., announced the closing of a USD 64 million Series B funding round. The funding is raised for the development of the innovative RENOVA iStim implantable tibial neuromodulation device under investigation for the treatment of urgency incontinence alone or in combination with urinary urgency and/or urinary frequency.
Segment Analysis
By Product, the market encompasses a range of devices designed to address urinary incontinence, including urethral slings, artificial urinary sphincters, electrical stimulation devices, and others. These products are tailored to meet the varying needs of patients with different severities of incontinence, offering both temporary and long-term solutions. The growing demand for advanced and minimally invasive products drives innovation in this segment.
The segmentation by Incontinence focuses on the specific types of urinary incontinence the devices address, such as stress urinary incontinence (SUI), urge urinary incontinence, overflow incontinence, and mixed incontinence. Each type presents unique challenges, and the devices are designed to provide targeted treatments. For example, stress urinary incontinence devices often focus on reinforcing pelvic structures, while urge incontinence devices aim to manage overactive bladder symptoms.
By Category, the market is divided into internal incontinence devices and external incontinence devices. Internal devices, such as slings and artificial sphincters, are used for more severe cases or for patients requiring surgical interventions. External devices, including catheters and absorbent products, cater to non-invasive management and are widely used for milder cases or temporary incontinence control.
The End User segmentation highlights the key areas where these devices are utilized, including hospitals, long-term care facilities, and others such as outpatient centers and homecare settings. Hospitals dominate the segment due to the prevalence of surgical treatments and advanced care facilities, while long-term care facilities and homecare settings are increasingly adopting devices to provide convenient and cost-effective management solutions for patients.
The Geography, the report analyzes the market's performance across key regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Each region's market is influenced by factors like healthcare infrastructure, awareness levels, and the prevalence of urinary incontinence, shaping the adoption rates and growth potential of treatment devices in these areas.
Global Urinary Incontinence Treatment Devices Segment Analysis
In this report, the Global Urinary Incontinence Treatment Devices Market has been segmented by Product, Incontinence, Category, End User, and Geography.
Global Urinary Incontinence Treatment Devices Market, Segmentation by Product
The Global Urinary Incontinence Treatment Devices Market has been segmented by Product into Urethral Slings, Electrical Stimulation Devices and Artificial Urinary Sphincters.
Urethral slings represent one of the most common treatment options for urinary incontinence, particularly in cases of stress urinary incontinence (SUI). These slings are typically made from synthetic materials or natural tissue and are surgically implanted to support the urethra and bladder neck, providing better control over urine leakage. The popularity of urethral slings stems from their effectiveness and relatively low invasiveness compared to other surgical procedures.
Electrical stimulation devices offer a non-invasive approach to managing urinary incontinence by targeting the nerves and muscles involved in bladder control. These devices use electrical impulses to stimulate the pelvic floor muscles, improving muscle tone and urinary control. They can be used alone or in conjunction with other treatments and are particularly beneficial for individuals who may not be suitable candidates for surgery or prefer non-surgical options.
Artificial urinary sphincters are implantable devices designed to mimic the function of the natural urinary sphincter, which controls the flow of urine from the bladder. These devices consist of a cuff that encircles the urethra, a pressure-regulating balloon, and a pump placed in the scrotum or labia. By manually activating the pump, the cuff can be inflated to prevent urine leakage, providing greater control over urinary function. Artificial urinary sphincters are often recommended for individuals with severe urinary incontinence or those who have not responded to other treatment options.
Global Urinary Incontinence Treatment Devices Market, Segmentation by Incontinence
The Global Urinary Incontinence Treatment Devices Market has been segmented by Incontinence into Stress Urinary Incontinence, Urge Urinary Incontinence, Mixed Incontinence and Overflow Incontinence.
Stress urinary incontinence (SUI) is characterized by the involuntary leakage of urine during activities that exert pressure on the bladder, such as coughing, sneezing, laughing, or exercising. It primarily affects women, especially those who have undergone childbirth or menopause. Treatment devices targeting SUI aim to provide support to the urethra or pelvic floor muscles to prevent leakage during moments of increased intra-abdominal pressure.
Urge urinary incontinence (UUI), also known as overactive bladder, involves a sudden and intense urge to urinate, often leading to leakage before reaching a restroom. This condition can significantly impact an individual's quality of life, causing embarrassment and social withdrawal. Treatment devices for UUI often focus on neuromodulation techniques, such as sacral nerve stimulation, to regulate bladder function and reduce urgency episodes.
Mixed incontinence occurs when individuals experience symptoms of both stress and urge urinary incontinence simultaneously. This combination presents unique challenges in treatment, as it requires addressing both the mechanical support needed for SUI and the overactive bladder symptoms characteristic of UUI. Treatment options may include a combination of devices targeting pelvic floor support and neuromodulation therapies to manage both aspects of the condition effectively.
Overflow incontinence occurs when the bladder is unable to empty completely, leading to constant dribbling or leakage of urine. This condition is often associated with bladder outlet obstruction or neurological disorders affecting bladder function. Treatment devices for overflow incontinence may include intermittent catheters or bladder management systems designed to empty the bladder efficiently and reduce the risk of leakage.
Global Urinary Incontinence Treatment Devices Market, Segmentation by Category
The Global Urinary Incontinence Treatment Devices Market has been segmented by Category into Internal Incontinence Devices and External Incontinence Devices.
Internal incontinence devices are designed for insertion into the body to provide structural support or regulate urinary flow. Examples include urethral inserts, vaginal pessaries, and implantable solutions like slings or artificial urinary sphincters. These devices are typically used for moderate to severe incontinence, often caused by weakened pelvic muscles or conditions such as stress urinary incontinence (SUI) or overactive bladder (OAB). Internal devices are favored for their effectiveness in long-term management but may require medical expertise for placement and maintenance.
External incontinence devices are non-invasive solutions that remain outside the body, designed to collect or absorb urine leakage. Examples include external catheters, male urinary sheaths, and absorbent pads or garments. These devices are ideal for mild to moderate incontinence or for patients who may not be candidates for invasive procedures. External devices are valued for their ease of use, comfort, and affordability, making them popular in both clinical and homecare settings. They are particularly beneficial for temporary use, such as during post-operative recovery or in elderly patients requiring simple management solutions.
The choice between internal and external devices depends on factors such as the severity of incontinence, patient preferences, and medical advice. While internal devices offer a more comprehensive and permanent solution for complex cases, external devices are appreciated for their accessibility and convenience, especially for short-term or less severe conditions. Together, these categories provide diverse options to enhance patient care and improve the quality of life for individuals managing urinary incontinence.
Global Urinary Incontinence Treatment Devices Market, Segmentation by End User
The Global Urinary Incontinence Treatment Devices Market has been segmented by End User into Hospitals, Ambulatory Surgery Centers, Clinics and Home Care.
Hospitals stand as significant pillars within the urinary incontinence treatment devices market due to their comprehensive infrastructure and expertise in handling complex medical cases. They offer a range of treatment options, from surgical interventions to non-invasive therapies, catering to patients with varying degrees of incontinence severity. Additionally, hospitals often serve as referral centers for specialized care, further enhancing their role in the market.
Ambulatory Surgery Centers (ASCs) have emerged as popular alternatives to traditional hospital settings, providing outpatient surgical procedures for urinary incontinence management. ASCs offer advantages such as reduced waiting times, cost-effectiveness, and personalized care, appealing to patients seeking convenience and efficiency in their treatment journey. The increasing trend towards minimally invasive procedures has further boosted the demand for urinary incontinence treatment devices in these settings.
Clinics play a vital role in the continuum of care for urinary incontinence patients, offering diagnostic evaluations, treatment consultations, and follow-up care. They serve as accessible points of care within communities, catering to individuals seeking specialized expertise in urology and gynecology. Clinics often deploy a multidisciplinary approach, incorporating various healthcare professionals, including urologists, gynecologists, and physical therapists, to provide comprehensive treatment plans tailored to individual patient needs.
Home care has gained prominence as a preferred setting for managing urinary incontinence, particularly among elderly and chronically ill individuals. The growing emphasis on aging in place and patient-centric care models has spurred the adoption of urinary incontinence treatment devices in home settings. These devices range from absorbent products and catheters to advanced electronic devices, empowering patients to maintain their independence and quality of life while managing their condition at home. Additionally, advancements in telemedicine and remote monitoring technologies have facilitated virtual consultations and support services, further enhancing the efficacy of urinary incontinence management in the home care setting.
Global Urinary Incontinence Treatment Devices Market, Segmentation by Geography
In this report, the Global Urinary Incontinence Treatment Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Urinary Incontinence Treatment Devices Market Share (%), by Geographical Region, 2024
North America holds a prominent position in the global urinary incontinence treatment devices market, driven by the high prevalence of urinary incontinence among the aging population and the availability of advanced healthcare infrastructure. Additionally, favorable reimbursement policies and the presence of key market players contribute to the region's market growth. The increasing adoption of minimally invasive surgical procedures and innovative technologies further propel market expansion in North America.
Europe is another significant market for urinary incontinence treatment devices, owing to the rising geriatric population and increasing healthcare expenditure in countries like Germany, the UK, and France. Moreover, the growing demand for advanced treatment options and the presence of established medical device manufacturers in the region bolster market growth. However, stringent regulatory requirements and healthcare budget constraints may hinder market growth to some extent.
In the Asia Pacific region, the urinary incontinence treatment devices market is witnessing rapid growth due to the increasing prevalence of urinary incontinence, particularly among the elderly population in countries such as China, Japan, and India. Rising healthcare expenditure, improving healthcare infrastructure, and growing awareness about urinary incontinence treatment options drive market expansion in this region. However, challenges such as limited access to advanced healthcare facilities in rural areas and pricing pressures may impede market growth.
The Middle East and Africa and Latin America regions are also witnessing significant growth in the urinary incontinence treatment devices market, albeit at a slower pace compared to other regions. Factors such as improving healthcare infrastructure, rising disposable income, and increasing healthcare expenditure contribute to market growth in these regions. However, challenges such as limited access to healthcare services in remote areas and cultural barriers may restrain market growth to some extent. Overall, the global urinary incontinence treatment devices market presents lucrative opportunities for market players across all geographical regions, driven by the rising prevalence of urinary incontinence and the growing demand for advanced treatment options.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Urinary Incontinence Treatment Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers
- Aging population
- Technological advancements
- Increasing awareness about treatment
-
Growing healthcare expenditure: The global urinary incontinence treatment devices market has witnessed significant growth in recent years, fueled in part by the increasing healthcare expenditure worldwide. As governments and private entities allocate more resources towards healthcare infrastructure, including improved diagnosis and treatment options for various conditions, the demand for advanced urinary incontinence treatment devices has risen. This rise in healthcare expenditure has enabled greater access to innovative medical technologies, enhancing the quality of life for individuals suffering from urinary incontinence.
As the global population ages, there is a growing prevalence of urinary incontinence, further driving the demand for treatment devices. Elderly individuals are particularly susceptible to urinary incontinence due to age-related changes in bladder function and pelvic muscles. With healthcare systems focusing on addressing the needs of aging populations, there has been a concerted effort to develop and deploy effective treatment devices for urinary incontinence. This demographic trend, coupled with increased healthcare spending, has created a conducive environment for market growth in this sector.
Advancements in medical technology have led to the development of more efficient and minimally invasive urinary incontinence treatment devices. These devices offer improved efficacy and patient outcomes while minimizing discomfort and recovery time. As healthcare providers and patients alike seek alternatives to traditional treatment methods such as medication or surgery, the demand for innovative urinary incontinence treatment devices continues to soar. The combination of rising healthcare expenditure, demographic shifts, and technological innovation is expected to sustain the growth trajectory of the global urinary incontinence treatment devices market in the foreseeable future.
Restraints
- High cost of devices
- Limited reimbursement policies
- Social stigma
-
Lack of skilled professionals: The global urinary incontinence treatment devices market has been experiencing significant growth over recent years, largely due to the rising prevalence of urinary incontinence worldwide. However, one of the key challenges facing this market is the lack of skilled professionals capable of effectively utilizing these devices. Urinary incontinence treatment often requires specialized knowledge and training to ensure optimal patient outcomes. From the initial diagnosis to the selection and fitting of appropriate devices, skilled professionals play a critical role in the management of urinary incontinence.
The shortage of skilled professionals in this field can hinder the adoption of urinary incontinence treatment devices and limit access to care for patients in need. Without proper guidance and support from knowledgeable healthcare providers, patients may struggle to find suitable treatment options or may experience suboptimal results with the devices they use. Additionally, the lack of skilled professionals may contribute to inconsistencies in the quality of care provided, leading to variations in patient outcomes across different healthcare settings.
Addressing the shortage of skilled professionals in the urinary incontinence treatment field requires targeted efforts to enhance education and training opportunities for healthcare providers. Investing in specialized training programs and continuing education initiatives can help equip healthcare professionals with the knowledge and skills needed to effectively manage urinary incontinence and utilize treatment devices appropriately. By ensuring a well-trained workforce, healthcare systems can better meet the needs of patients with urinary incontinence and improve overall quality of care in this important area of healthcare.
Opportunities
- Emerging markets
- Innovative product development
- Telemedicine and remote monitoring
-
Strategic partnerships and collaborations: In recent years, the global urinary incontinence treatment devices market has witnessed a surge in strategic partnerships and collaborations among key players. These collaborations have been driven by the need for innovation, expanded market presence, and the pursuit of comprehensive solutions to address the diverse needs of patients suffering from urinary incontinence. By joining forces, companies can leverage each other's strengths in research and development, manufacturing capabilities, and distribution networks to bring advanced products to market more efficiently.
One notable trend in strategic partnerships is the collaboration between medical device manufacturers and healthcare providers or research institutions. These partnerships often involve joint research projects aimed at developing cutting-edge technologies for urinary incontinence treatment. By combining the expertise of device manufacturers with the clinical insights of healthcare providers, these collaborations can lead to the creation of more effective and patient-friendly treatment solutions. Additionally, partnerships with research institutions can accelerate the pace of innovation by providing access to funding, resources, and specialized expertise.
Strategic partnerships and collaborations have become increasingly important for expanding market reach and accessing new customer segments. By teaming up with other companies, urinary incontinence device manufacturers can tap into existing distribution channels and penetrate new geographical markets more effectively. Collaborations with healthcare organizations and advocacy groups also enable companies to raise awareness about urinary incontinence and educate patients and healthcare professionals about available treatment options. Overall, strategic partnerships play a vital role in driving innovation, fostering growth, and improving patient outcomes in the global urinary incontinence treatment devices market.
Competitive Landscape Analysis
Key players in Global Urinary Incontinence Treatment Devices Market include:
- Boston Scientific Corporation
- C.R. Bard, Inc
- Ethicon
- Coloplast A/S
- Medtronic plc
- Kimberly-Clark Corporation
- Hollister Incorporated
- Teleflex Incorporated
- ConvaTec Group plc
- B. Braun Melsungen AG
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Incontinence
- Market Snapshot, By Category
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Urinary Incontinence Treatment Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Aging population
- Technological advancements
- Increasing awareness about treatment
- Growing healthcare expenditure
- Restraints
- High cost of devices
- Limited reimbursement policies
- Social stigma
- Lack of skilled professionals
- Opportunities
- Emerging markets
- Innovative product development
- Telemedicine and remote monitoring
- Strategic partnerships and collaborations
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Urinary Incontinence Treatment Devices Market, By Product, 2021 - 2031 (USD Million)
- Urethral Slings
- Female Slings
- Male Slings
- Electrical Stimulation Devices
- Implantable
- Non-Implantable
- Artificial Urinary Sphincters
- Urethral Slings
- Global Urinary Incontinence Treatment Devices Market, By Incontinence, 2021 - 2031 (USD Million)
- Stress Urinary Incontinence
- Urge Urinary Incontinence
- Mixed Incontinence
- Overflow Incontinence
- Global Urinary Incontinence Treatment Devices Market, By Category, 2021 - 2031 (USD Million)
- Internal Incontinence Devices
- External Incontinence Devices
- Global Urinary Incontinence Treatment Devices Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgery Centers
- Clinics
- Home Care
- Global Urinary Incontinence Treatment Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Urinary Incontinence Treatment Devices Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Boston Scientific Corporation
- C.R. Bard, Inc
- Ethicon
- Coloplast A/S
- Medtronic plc
- Kimberly-Clark Corporation
- Hollister Incorporated
- Teleflex Incorporated
- ConvaTec Group plc
- B. Braun Melsungen AG
- Company Profiles
- Analyst Views
- Future Outlook of the Market